Simply replacing the connector in the IV system in patients with central lines could help reduce deadly bloodstream infections, researchers at Georgia Regents University have found.
Most connectors use positive or negative pressure either pushing fluid out or drawing blood in when catheters are disconnected for flushing and cleaning. Ironically, its during that process designed to clean the catheter and ultimately reduce the chance of infection that germs find their way into the bloodstream causing an often dangerous blood infection. Nearly 250,000 central line-associated bloodstream infections happen in hospitals each year, according to the Centers for Disease Control and Prevention. Mortality rates on CLABSIs range from 12 percent to 25 percent.
Treating them also costs health care systems billions of dollars each year.
We know that both positive and negative needleless connectors have been associated with higher CLABSI rates, so we decided to see what role a zero fluid displacement connector would play in infection control, says Cynthia C. Chernecky, a professor of nursing at GRU and corresponding author on the study published in the American Journal of Infection Control.
As their name indicates, zero fluid displacement connectors cause no reflux of fluids out or in during disconnection and connection.
Researchers analyzed data in six acute care settings in five states and found that the number of infections decreased by 60 percent when positive connectors were replaced with zero fluid displacement connectors and by 94 percent when negative connectors were replaced with the zero connectors for central line IV therapy.
We estimate that replacing the connector devices saved about 13 lives in the acute care settings in this study, Chernecky said. In addition to saving lives, more than $3 million was saved on health care costs. The average central line-associated bloodstream infection costs about $35,000 to treat.
Â
Zero connectors cost about $1 a piece, Chernecky said. This is a very cost-effective way to increase patient safety.
Coauthors on the study are Thomas Joshua, an assistant professor of nursing at GRU; Denise Macklin, a nurse consultant in Marietta, Ga.; and William R. Jarvis, MD, a healthcare epidemiology and infection control consultant with Jarvis & Jarvis Associates, and former acting director of the CDCs Hospital Infection Program.
While the results are promising, study authors say that more research is needed.
Central line-associated bloodstream infections can be deadly, so we must continue to investigate best practices to reduce risks and protect patients, Chernecky says.
Source: Georgia Regents University
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.